Hologic Stock Performance

HOLX Stock  USD 75.02  0.17  0.23%   
Hologic has a performance score of 11 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 0.33, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Hologic's returns are expected to increase less than the market. However, during the bear market, the loss of holding Hologic is expected to be smaller as well. Hologic right now retains a risk of 1.03%. Please check out Hologic maximum drawdown, as well as the relationship between the skewness and day typical price , to decide if Hologic will be following its current trending patterns.

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Hologic are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating essential indicators, Hologic may actually be approaching a critical reversion point that can send shares even higher in January 2026. ...more

Actual Historical Performance (%)

One Day Return
(0.23)
Five Day Return
0.0934
Year To Date Return
4.57
Ten Year Return
92.41
All Time Return
K
Last Split Factor
2:1
Last Split Date
2008-04-03
1
Hologic One-Off 277.8M Loss Undermines Recovery Narrative Despite Growth Forecasts
11/05/2025
2
Heres Why Hologic is a Strong Momentum Stock
11/12/2025
3
Hologic, Inc. Is a Trending Stock Facts to Know Before Betting on It
12/01/2025
4
Artificial Intelligence in in Vitro Diagnostics Market Research Report 2025
12/02/2025
5
Why Is Hologic Up 1 percent Since Last Earnings Report
12/03/2025
6
Hologics BCI Test Shows Growing Impact in Endocrine Therapy Decisions
12/04/2025
7
WTAs record-breaking Mercedes deal allows womens tennis to wipe slate clean
12/10/2025
8
BRODSKY SMITH SHAREHOLDER UPDATE Notifying Investors of the Following Investigations Diamond Hill Investment Group, Inc. , Synchronoss Technologies , Forge Glob...
12/11/2025
9
What Is Driving Hologics Strength in the US Diagnostics Market
12/12/2025
Begin Period Cash Flow2.2 B
Total Cashflows From Investing Activities-482.7 M

Hologic Relative Risk vs. Return Landscape

If you would invest  6,820  in Hologic on September 17, 2025 and sell it today you would earn a total of  682.00  from holding Hologic or generate 10.0% return on investment over 90 days. Hologic is currently generating 0.1542% in daily expected returns and assumes 1.0261% risk (volatility on return distribution) over the 90 days horizon. In different words, 9% of stocks are less volatile than Hologic, and 97% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Hologic is expected to generate 1.45 times more return on investment than the market. However, the company is 1.45 times more volatile than its market benchmark. It trades about 0.15 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.1 per unit of risk.

Hologic Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Hologic's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Hologic, and traders can use it to determine the average amount a Hologic's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.1503

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsHOLX
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns
Based on monthly moving average Hologic is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Hologic by adding it to a well-diversified portfolio.

Hologic Fundamentals Growth

Hologic Stock prices reflect investors' perceptions of the future prospects and financial health of Hologic, and Hologic fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Hologic Stock performance.

About Hologic Performance

Evaluating Hologic's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Hologic has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Hologic has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 158.31  118.62 
Return On Tangible Assets 0.16  0.15 
Return On Capital Employed 0.14  0.08 
Return On Assets 0.10  0.10 
Return On Equity 0.14  0.15 

Things to note about Hologic performance evaluation

Checking the ongoing alerts about Hologic for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Hologic help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Over 100.0% of the company shares are owned by institutional investors
Latest headline from zacks.com: What Is Driving Hologics Strength in the US Diagnostics Market
Evaluating Hologic's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Hologic's stock performance include:
  • Analyzing Hologic's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Hologic's stock is overvalued or undervalued compared to its peers.
  • Examining Hologic's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Hologic's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Hologic's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Hologic's stock. These opinions can provide insight into Hologic's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Hologic's stock performance is not an exact science, and many factors can impact Hologic's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Additional Tools for Hologic Stock Analysis

When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.